PF-Atlas › Clinical Trials › NCT04155632

Neurocircuit Strategy to Decrease Cocaine Cue Reactivity

N-acetylcysteine · Phase 2

Registry ID
NCT04155632
Phase
Phase 2
Status
Completed
Drug / intervention
N-acetylcysteine
Sponsor
Medical University of South Carolina
Start
2020-12-18
Enrollment
32
Locations
1

About this trial

The overarching goal of this project is to examine the effect of combining theta burst stimulation (TBS) and N-acetylcysteine (NAC) on cocaine craving and brain response to cocaine-related images.

View NCT04155632 on ClinicalTrials.gov →

Explore related

All N-acetylcysteine trialsAll IPF trials

Related trials

N-acetylcysteine — NCT00650091N-acetylcysteine — NCT02088216N-acetylcysteine — NCT03956888
Medical disclaimer. This page summarizes public trial data for NCT04155632 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.